Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Phase 2 study of AKB-6548, a novel hypoxia-inducible factor prolyl-hydroxylase inhibitor (HIF-PHI) in patients with end stage renal disease (ESRD) undergoing hemodialysis (HD)
It has the molecular formula C 14 H 22 CuN 6 O 4 , a molecular weight of 401.9 g/mol, and CAS number 89030-95-5
WARNINGS: Do not use if pregnant or planning to become pregnant or breastfeeding
Side effects are rare but may include mild pain at the injection site or slight nausea
Degradation mechanisms Copper peptides degrade through several temperature-dependent processes
The results have been encouraging, from measurable improvements in tissue quality to patients simply feeling better in their skin
US$ 21.89
US$ 29.48
US$ 28.49
US$ 28.87
US$ 27.97
US$ 24.68
